Literature DB >> 25577467

Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.

Jamie E Mells1, Ping P Fu2, Pradeep Kumar2, Tekla Smith2, Saul J Karpen1, Frank A Anania3.   

Abstract

UNLABELLED: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome (MetS). Up to a third of NAFLD subjects are at risk for developing nonalcoholic steatohepatitis (NASH). Many rodent models fail to replicate both MetS and NASH. The purpose of this study was to develop a reliable mouse model of NASH and MetS using a diet containing cholesterol, saturated fat and carbohydrate that is reflective of Western diets of North Americans. EXPERIMENTAL
DESIGN: We used adult male C57BL/6 J 4- to 5-week-old mice and administered a solid diet containing 0.2% cholesterol, 45% of its calories from fat, with 30% of the fat in the form of partially hydrogenated vegetable oil. We also provided carbohydrate largely as high-fructose corn syrup equivalent in water. In a separate cohort, we gave the identical diet in the absence of cholesterol. Glucose and insulin tolerance testing was conducted throughout the feeding period. The feeding was conducted for 16 weeks, and the mice were sacrificed for histological analysis, markers of MetS, liver inflammation, circulating lipids, as well as liver staining for fibrosis and alpha smooth muscle actin (α-SMA).
RESULTS: We found that cholesterol significantly increased serum leptin, interleukin-6, liver weight and liver weight/body weight ratio, fibrosis and liver α-SMA.
CONCLUSIONS: Mice administered a diet accurately reflecting patterns associated with humans afflicted with MetS can reliably replicate features of MetS, NASH and significant liver fibrosis. The model we describe significantly reduces the time by several months for development of stage 3 hepatic fibrosis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adipocytokine; Cholesterol; Fibrosis; Fructose; NASH

Mesh:

Substances:

Year:  2014        PMID: 25577467      PMCID: PMC4727836          DOI: 10.1016/j.jnutbio.2014.11.002

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  48 in total

1.  Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women.

Authors:  Karen L Teff; Sharon S Elliott; Matthias Tschöp; Timothy J Kieffer; Daniel Rader; Mark Heiman; Raymond R Townsend; Nancy L Keim; David D'Alessio; Peter J Havel
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

2.  Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.

Authors:  Xiaokun Ding; Neeraj K Saxena; Songbai Lin; Nitika Arora Gupta; Narita Gupta; Frank A Anania
Journal:  Hepatology       Date:  2006-01       Impact factor: 17.425

3.  Good fat/bad fat.

Authors:  Craig J McClain; Shirish Barve; Ion Deaciuc
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

4.  Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats.

Authors:  Núria Roglans; Laia Vilà; Mireia Farré; Marta Alegret; Rosa María Sánchez; Manuel Vázquez-Carrera; Juan Carlos Laguna
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

5.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

6.  Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice.

Authors:  R S Surwit; S Wang; A E Petro; D Sanchis; S Raimbault; D Ricquier; S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 7.  Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment.

Authors:  Tim C M A Schreuder; Bart J Verwer; Carin M J van Nieuwkerk; Chris J J Mulder
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

8.  Reversal of diet-induced obesity and diabetes in C57BL/6J mice.

Authors:  P I Parekh; A E Petro; J M Tiller; M N Feinglos; R S Surwit
Journal:  Metabolism       Date:  1998-09       Impact factor: 8.694

9.  Fructose consumption as a risk factor for non-alcoholic fatty liver disease.

Authors:  Xiaosen Ouyang; Pietro Cirillo; Yuri Sautin; Shannon McCall; James L Bruchette; Anna Mae Diehl; Richard J Johnson; Manal F Abdelmalek
Journal:  J Hepatol       Date:  2008-03-10       Impact factor: 25.083

10.  Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse.

Authors:  Ann E Petro; Juliann Cotter; Dale A Cooper; John C Peters; Sarah J Surwit; Richard S Surwit
Journal:  Metabolism       Date:  2004-04       Impact factor: 8.694

View more
  28 in total

1.  Mouse Models of Liver Fibrosis.

Authors:  Aashreya Ravichandra; Robert F Schwabe
Journal:  Methods Mol Biol       Date:  2021

2.  Modeling fatty liver disease in animals: Is there an optimal approach, and is the effort worthwhile?

Authors:  Jacquelyn J Maher
Journal:  Hepatology       Date:  2016-09-30       Impact factor: 17.425

3.  Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.

Authors:  Melissa A Linden; Ryan D Sheldon; Grace M Meers; Laura C Ortinau; E Matthew Morris; Frank W Booth; Jill A Kanaley; Victoria J Vieira-Potter; James R Sowers; Jamal A Ibdah; John P Thyfault; M Harold Laughlin; R Scott Rector
Journal:  J Physiol       Date:  2016-05-27       Impact factor: 5.182

4.  Prolonged intake of desloratadine: mesenteric lymphatic vessel dysfunction and development of obesity/metabolic syndrome.

Authors:  Olga Y Gasheva; Irina Tsoy Nizamutdinova; Laura Hargrove; Cassidy Gobbell; Maria Troyanova-Wood; Sally F Alpini; Sarit Pal; Christina Du; Angie R Hitt; Vlad V Yakovlev; M Karen Newell-Rogers; David C Zawieja; Cynthia J Meininger; Gianfranco D Alpini; Heather Francis; Anatoliy A Gashev
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-11-26       Impact factor: 4.052

5.  Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis in mice.

Authors:  Jung Eun Jang; Han-Sol Park; Hyun Ju Yoo; In-Jeoung Baek; Ji Eun Yoon; Myoung Seok Ko; Ah-Ram Kim; Hyoun Sik Kim; Hye-Sun Park; Seung Eun Lee; Seung-Whan Kim; Su Jung Kim; Jaechan Leem; Yu Mi Kang; Min Kyo Jung; Chan-Gi Pack; Chong Jai Kim; Chang Ohk Sung; In-Kyu Lee; Joong-Yeol Park; José C Fernández-Checa; Eun Hee Koh; Ki-Up Lee
Journal:  Hepatology       Date:  2017-06-29       Impact factor: 17.425

6.  Isocaloric manipulation of macronutrients within a high-carbohydrate/moderate-fat diet induces unique effects on hepatic lipogenesis, steatosis and liver injury.

Authors:  Andrew A Pierce; Caroline C Duwaerts; Russell K Soon; Kevin Siao; James P Grenert; Mark Fitch; Marc K Hellerstein; Carine Beysen; Scott M Turner; Jacquelyn J Maher
Journal:  J Nutr Biochem       Date:  2015-11-17       Impact factor: 6.048

Review 7.  Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights.

Authors:  Kristen Stephenson; Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Joanne Thomson; Gianfranco Alpini; Heather Francis
Journal:  Gene Expr       Date:  2017-11-02

8.  Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol.

Authors:  Khalidur Rahman; Chirayu Desai; Smita S Iyer; Natalie E Thorn; Pradeep Kumar; Yunshan Liu; Tekla Smith; Andrew S Neish; Hongliang Li; Shiyun Tan; Pengbo Wu; Xiaoxiong Liu; Yuanjie Yu; Alton B Farris; Asma Nusrat; Charles A Parkos; Frank A Anania
Journal:  Gastroenterology       Date:  2016-06-21       Impact factor: 22.682

9.  Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.

Authors:  Anuradha Rao; Astrid Kosters; Jamie E Mells; Wujuan Zhang; Kenneth D R Setchell; Angelica M Amanso; Grace M Wynn; Tianlei Xu; Brad T Keller; Hong Yin; Sophia Banton; Dean P Jones; Hao Wu; Paul A Dawson; Saul J Karpen
Journal:  Sci Transl Med       Date:  2016-09-21       Impact factor: 17.956

10.  Effects of glucomannan/spirulina-surimi on liver oxidation and inflammation in Zucker rats fed atherogenic diets.

Authors:  Miguel Vázquez-Velasco; Laura González-Torres; Patricia López-Gasco; Sara Bastida; Juana Benedí; María José González-Muñoz; Francisco J Sánchez-Muniz
Journal:  J Physiol Biochem       Date:  2015-08-04       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.